Girish Prabhu

Girish Prabhu

Auto-generated profile, based on publicly available information

Girish Prabhu

Professor, Department of General Medicine, SVMCH&RC, Pondicherry, India

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
PDF file
SRSima Kianpour Rad
Sima Kianpour Rad
AAAditya Arya
Aditya Arya
HKHamed Karimian
Hamed Karimian
PMPriya Madhavan
Priya Madhavan
FRFarzana Rizwan
Farzana Rizwan
GPGirish Prabhu
Girish Prabhu
The pathophysiological link between type 2 diabetes mellitus (T2DM) and Alzheimer’s disease (AD) has been suggested in several reports. Few findings suggest that T2DM has strong link in the development process of AD, and the complete mechanism is yet to be revealed. Formation of amyloid plaques (APs) and neurofibrillary tangles (NFTs) are two central hallmarks in the AD. APs are the dense composites of β-amyloid protein (Aβ) which accumulates around the nerve cells. Moreover, NFTs are the twisted fibers containing hyperphosphorylated tau proteins present in certain residues of Aβ that build up inside the brain cells. Certain factors contribute to the aetiogenesis of AD by regulating insulin signaling pathway in the brain and accelerating the formation of neurotoxic Aβ and NFTs via various mechanisms, including GSK3β, JNK, CamKII, CDK5, CK1, MARK4, PLK2, Syk, DYRK1A, PPP, and P70S6K. Progression to AD could be influenced by insulin signaling pathway that is affected due to T2DM. Interestingly, NFTs and APs lead to the impairment of several crucial cascades, such as synaptogenesis, neurotrophy, and apoptosis, which are regulated by insulin, cholesterol, and glucose metabolism. The investigation of the molecular cascades through insulin functions in brain contributes to probe and perceive progressions of diabetes to AD. This review elaborates the molecular insights that would help to further understand the potential mechanisms linking T2DM and AD.

11 August 2021 in International Journal of Medical Research & Review
Verified
Journal Article
Open access
PDF file
APA Ponnambalam
A Ponnambalam
MAM Arun
M Arun
GPG. Prabhu
G. Prabhu
Background: Type 2 diabetes mellitus (DM) is associated with increased morbidity and mortality due to the development of complications, especially due to poor glycemic control. Besides its role in calcium homeostasis, Vitamin D has been involved in the pathophysiology as well as glycemic control of type 2 DM. Methods: 100 patients diagnosed with type 2 DM were included. Vitamin D levels along with glycosylated haemoglobin were measured in all the individuals. Results: Vitamin D deficiency was observed in 48% of the patients. Vitamin D levels were not associated with markers of glycemic control (HbA1c). Conclusions: Hypovitaminosis D was observed nearly in half of the patients with type 2 diabetes, suggesting a potential for vitamin D supplementation in type 2 DM patients.